|
|
Blood, 1 November 2007, Vol. 110, No. 9, pp. 3202-3208.
Prepublished online as a Blood First Edition Paper on July 20, 2007; DOI 10.1182/blood-2007-02-075366.
 Previous Article | Next Article 
Submitted February 20, 2007
Accepted July 5, 2007
The p110delta catalytic isoform of PI3K is a key player in NK cell development and cytokine secretion
Nayoung Kim, Aurore Saudemont, Louise Webb, Montserrat Camps, Thomas Ruckle, Emilio Hirsch, Martin Turner, and Francesco Colucci*
Laboratory of Lymphocyte Signalling and Developpment, Babraham Institute, Cambridge, United Kingdom
Merck Serono Research Centre, Merck Serono, Geneva, Switzerland
Dipartimento di Genetica, Biologia e Biochimica, Centre for Molecular Biotechnology, Torino, Italy
* Corresponding author; email: francesco.colucci{at}bbsrc.ac.uk.
The signal transduction pathways that lead activated natural killer (NK) cells to produce cytokines, releases cytotoxic granules, or do both, are not clearly dissected. For example, phosphoinositide 3-kinases (PI3Ks) are key players in the execution of both functions, but the relative contribution of each isoform is unknown. We show here that the catalytic isoform p110 , not p110 , was required for interferon- (IFN-), tumour necrosis factor- (TNF-) and granulocyte macrophage colony stimulating factor (GM-CSF) secretion, whereas neither was necessary for cytotoxicity. Yet, when both p110 and p110 isoforms were inactivated by a combination of genetic and biochemical approaches, cytotoxicity was decreased. NK cell numbers were also affected by the lack of p110 but not p110 and more severely so in mice lacking both subunits. These results provide genetic evidence that p110 is the dominant PI3K isoform for cytokine secretion by NK cells and suggest that PI3Ks cooperate during NK cell development and cytotoxicity.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
N. J. Meyer, Y. Huang, P. A. Singleton, S. Sammani, J. Moitra, C. L. Evenoski, A. N. Husain, S. Mitra, L. Moreno-Vinasco, J. R. Jacobson, et al.
GADD45a is a novel candidate gene in inflammatory lung injury via influences on Akt signaling
FASEB J,
May 1, 2009;
23(5):
1325 - 1337.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Saudemont, F. Garcon, H. Yadi, M. Roche-Molina, N. Kim, A. Segonds-Pichon, A. Martin-Fontecha, K. Okkenhaug, and F. Colucci
p110{gamma} and p110{delta} isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease
PNAS,
April 7, 2009;
106(14):
5795 - 5800.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Zebedin, O. Simma, C. Schuster, E. M. Putz, S. Fajmann, W. Warsch, E. Eckelhart, D. Stoiber, E. Weisz, J. A. Schmid, et al.
Leukemic challenge unmasks a requirement for PI3K{delta} in NK cell-mediated tumor surveillance
Blood,
December 1, 2008;
112(12):
4655 - 4664.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Konrad, S. R. Ali, K. Wiege, S. N. Syed, L. Engling, R. P. Piekorz, E. Hirsch, B. Nurnberg, R. E. Schmidt, and J. E. Gessner
Phosphoinositide 3-Kinases {gamma} and {delta}, Linkers of Coordinate C5a Receptor-Fc{gamma} Receptor Activation and Immune Complex-induced Inflammation
J. Biol. Chem.,
November 28, 2008;
283(48):
33296 - 33303.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Guo, A. Samarakoon, B. Vanhaesebroeck, and S. Malarkannan
The p110{delta} of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation
J. Exp. Med.,
September 29, 2008;
205(10):
2419 - 2435.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
